Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.8%

2 terminated/withdrawn out of 113 trials

Success Rate

94.3%

+7.8% vs industry average

Late-Stage Pipeline

4%

4 trials in Phase 3/4

Results Transparency

36%

12 of 33 completed trials have results

Key Signals

47 recruiting12 with results

Enrollment Performance

Analytics

N/A
61(60.4%)
Phase 1
18(17.8%)
Phase 2
15(14.9%)
Early Phase 1
3(3.0%)
Phase 4
2(2.0%)
Phase 3
2(2.0%)
101Total
N/A(61)
Phase 1(18)
Phase 2(15)
Early Phase 1(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (113)

Showing 20 of 113 trials
NCT06441617Not ApplicableRecruiting

Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis

Role: collaborator

NCT07521657Phase 2Not Yet Recruiting

Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma

Role: collaborator

NCT07325513Not ApplicableRecruiting

Machine Learning in Guiding rTMS Treatment for GWI-Related Headaches and Body Pain

Role: collaborator

NCT07090473Not ApplicableRecruiting

Safety of Transcutaneous Electrical Stimulation Potentiating Recovery in Acute Spinal Cord Injury Syndromes

Role: collaborator

NCT07176936Not ApplicableRecruiting

Improving Speech in Noise Using Noninvasive Stimulation

Role: collaborator

NCT07073794Phase 2Recruiting

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

Role: collaborator

NCT07210255Not ApplicableRecruiting

SAINT in Postpartum Depression (PPD)

Role: collaborator

NCT06521723Not ApplicableRecruiting

Low Oxygen Therapy to Enhance Walking Recovery After SCI.

Role: collaborator

NCT07467707Phase 3Not Yet Recruiting

An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults

Role: collaborator

NCT07280351Not ApplicableNot Yet Recruiting

Duraplasty for Acute Traumatic Spinal Cord Injury

Role: collaborator

NCT07227987Not ApplicableNot Yet Recruiting

Cognitive Rehabilitation for Treatment of Anger in Veterans With TBI and PTSD

Role: collaborator

NCT06134375Phase 1Recruiting

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

Role: collaborator

NCT06188741Phase 2Recruiting

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Role: collaborator

NCT04430218Not ApplicableRecruiting

Peripheral Interfaces in Amputees for Sensorimotor Integration

Role: collaborator

NCT05903859Phase 3Recruiting

Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)

Role: collaborator

NCT05045066Early Phase 1Recruiting

Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

Role: collaborator

NCT06587841Not ApplicableRecruiting

Noninvasive Spinal Cord Stimulation for Early SCI

Role: collaborator

NCT07430592Phase 2Not Yet Recruiting

This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria

Role: collaborator

NCT07076498Phase 1Not Yet Recruiting

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

Role: collaborator

NCT06438471Phase 1Recruiting

Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury

Role: collaborator